|
CDC16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.5606963478283E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.72009978377719E-10 |
| Normal-vs-Stage2 |
1.73728999999234E-05 |
| Normal-vs-Stage3 |
1.031070E-04 |
| Normal-vs-Stage4 |
3.69560000001989E-06 |
| Stage1-vs-Stage2 |
3.441000E-01 |
| Stage1-vs-Stage3 |
1.075220E-01 |
| Stage1-vs-Stage4 |
5.946600E-01 |
| Stage2-vs-Stage3 |
5.889700E-02 |
| Stage2-vs-Stage4 |
7.567800E-01 |
| Stage3-vs-Stage4 |
1.164960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.4709994574439E-10 |
| Normal-vs-AfricanAmerican |
2.10339999973108E-07 |
| Normal-vs-Asian |
2.788800E-04 |
| Caucasian-vs-AfricanAmerican |
7.421600E-02 |
| Caucasian-vs-Asian |
3.585800E-01 |
| AfricanAmerican-vs-Asian |
8.354800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01180000436452E-08 |
| Normal-vs-Female |
5.01498842453429E-12 |
| Male-vs-Female |
2.504100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.078400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.1022961149697E-11 |
| Normal-vs-Age(61-80Yrs) |
2.62070000145442E-08 |
| Normal-vs-Age(81-100Yrs) |
6.672200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.718610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.759000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.265000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.392210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.439000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.816400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.772800E-04 |
| Normal-vs-Grade 2 |
3.31124017094453E-12 |
| Normal-vs-Grade 3 |
3.71139999844061E-08 |
| Normal-vs-Grade 4 |
1.065870E-02 |
| Grade 1-vs-Grade 2 |
5.547500E-02 |
| Grade 1-vs-Grade 3 |
2.090400E-02 |
| Grade 1-vs-Grade 4 |
3.782900E-03 |
| Grade 2-vs-Grade 3 |
1.307050E-01 |
| Grade 2-vs-Grade 4 |
5.577800E-03 |
| Grade 3-vs-Grade 4 |
1.146210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.4432899320127E-15 |
| Normal-vs-ccB subtype |
4.376400E-03 |
| ccA subtype-vs-ccB subtype |
1.24769999998442E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.66450000133645E-08 |
| Normal-vs-N1 |
7.920500E-02 |
| N0-vs-N1 |
8.680600E-01 |
|
|
